Portosystemic Shunt-associated Pulmonary Hypertension Multi-center Prospective Cohort Study
- Sponsor
- Chinese Pulmonary Vascular Disease Research Group
- Study ID
- NCT07481877
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Portosystemic Shunt
- Pulmonary Hypertension
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
This study aims to establish a multi-center registry cohort of portosystemic shunt-associated pulmonary hypertension, with the goal of clarifying the epidemiology, clinical features, phenotypic classification, response to targeted therapy, and prognostic outcomes in patients with portosystemic shunt-associated pulmonary hypertension.
Key Dates
- First listed
- Mar 19, 2026
- Start date
- Apr 1, 2026
- Status verified
- Mar 2026
- Primary completion
- Apr 1, 2031
- Completion
- Apr 1, 2031
Study Design
- Enrollment
- 300 participants (estimated)
Arms
- Arm: Portosystemic shunt-associated pulmonary hypertension
Primary Outcome Measure
Clinical worsening [ Time Frame: Up to 24 months ]
Central Contacts
- Zhihong Liu, MD, PhD+86 13269276067
Related Studies
- Investigation of Dysynchrony in Patients With Pulmonary HypertensionEnrolling By Invitation · Stanford University · Stanford, California
- Natural History Study of Biomarkers in Pulmonary Arterial HypertensionRecruiting · National Institutes of Health Clinical Center (CC) · Bethesda, Maryland
- MRI and Computational Simulation Cardiology StudyEnrolling By Invitation · Stanford University · Palo Alto, California
- New Orleans Pulmonary Hypertension BiobankRecruiting · Louisiana State University Health Sciences Center in New Orleans · New Orleans, Louisiana